Assessing Liver Function in Patients with HCC : Episode 5
Assessing Liver Function in Patients With HCC: The MELD Score
Rachna Shroff, MD, MS, FASCO, and Amit Singal, MD, discuss the use of various liver function assessment scores—Child-Pugh, ALBI, and MELD—in the care of patients with hepatocellular carcinoma, emphasizing their pros, cons, and roles in treatment decision-making.
EP: 1.Risk Factors of Hepatocellular Carcinoma (HCC)
EP: 2.Importance of Assessing Liver Function in HCC
EP: 3.Assessing Liver Function in Patients With HCC: The ALBI Score
EP: 4.Assessing Liver Function in Patients With HCC: The Child-Pugh Score
Now Viewing
EP: 5.Assessing Liver Function in Patients With HCC: The MELD Score
EP: 6.Updates in First-Line Systemic Therapy for Patients With HCC
EP: 7.Key Outcomes Data in Patients With HCC Based on Liver Function
EP: 8.Rivoceranib plus Camrelizumab for First-Line Treatment of HCC: Data from CARES-310
EP: 9.The Future of Liver Function Assessments in HCC
Related Videos
Related Content
